Conversion of the Major Birch Pollen Allergen, Bet v 1, Into Two Nonanaphylactic T Cell Epitope-Containing Fragments: Candidates for a Novel Form of Specific Immunotherapy.
Journal of Clinical Investigation- United States
doi 10.1172/jci119330
Full Text
Abstract
Available in
Categories
Date
April 1, 1997
Authors
Publisher
American Society for Clinical Investigation